Baillie Gifford & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610M | Sell |
|
|||||
|
2025
Q1 | $707M | Sell |
|
|||||
|
2024
Q4 | $1.62B | Sell |
|
|||||
|
2024
Q3 | $2.84B | Sell |
|
|||||
|
2024
Q2 | $5.16B | Sell |
|
|||||
|
2024
Q1 | $4.76B | Sell |
|
|||||
|
2023
Q4 | $4.54B | Buy |
|
|||||
|
2023
Q3 | $4.72B | Sell |
|
|||||
|
2023
Q2 | $5.55B | Sell |
|
|||||
|
2023
Q1 | $7.14B | Buy |
|
|||||
|
2022
Q4 | $8.04B | Sell |
|
|||||
|
2022
Q3 | $5.35B | Sell |
|
|||||
|
2022
Q2 | $6.51B | Sell |
|
|||||
|
2022
Q1 | $7.86B | Sell |
|
|||||
|
2021
Q4 | $11.6B | Buy |
|
|||||
|
2021
Q3 | $16.2B | Sell |
|
|||||
|
2021
Q2 | $10.8B | Buy |
|
|||||
|
2021
Q1 | $5.94B | Buy |
|
|||||
|
2020
Q4 | $2.54B | Buy |
|
|||||
|
2020
Q3 | $511M | Buy |
|
|||||
|
2020
Q2 | $261M | Buy |
|
|||||
|
2020
Q1 | $107M | Buy |
|
|||||
|
2019
Q4 | $66.8M | Buy |
|
|||||
|
2019
Q3 | $51.2M | Buy |
|
|||||
|
2019
Q2 | $47M | Buy |
|
|||||
|
2019
Q1 | $52.4M | Buy |
|
|||||
|
2018
Q4 | $26.4M | Buy |
|